Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. (2019)
Attributed to:
Large scale lentiviral vector production
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.126243
PubMed Identifier: 31167965
Publication URI: http://europepmc.org/abstract/MED/31167965
Type: Journal Article/Review
Volume: 4
Parent Publication: JCI insight
Issue: 11
ISSN: 2379-3708